However, persistent hunger may point to a deeper underlying issue. Some children experience an insatiable appetite, also ...

The Mets need a boost in the bullpen very badly. They also can use an upgrade in centerfield. This trade with the Twins would answer both those issues.

Next month will be the first opportunity to gauge the commercial launch of a new treatment for Prader-Willi syndrome, a rare genetic disease that causes an insatiable desire to eat.

Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15. The Prader-Willi Syndrome Association USA estimates that ...

Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15. The Prader-Willi Syndrome Association USA estimates that PWS ...

Additionally, the U.S. Food and Drug Administration approved VYKAT XR earlier this year, marking it as the first commercial treatment for hyperphagia associated with Prader-Willi syndrome.

Soleno Therapeutics will present research on Prader-Willi syndrome at the upcoming International PWS Conference in Phoenix, AZ.

About PWS Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15.

Story Continues About PWS Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15.

For Prader-Willi, two other notable phase 3 clinical trials are underway, led by Acadia Pharmaceuticals and Aardvark Therapeutics, each targeting different pathways.